Effects of the topical hemostatic agent Ankaferd Blood Stopper on the incidence of alveolar osteitis after surgical removal of an impacted mandibular third molar

dc.authorid0000-0002-0073-3170en_US
dc.contributor.authorTek, Mustafa
dc.contributor.authorAkkaş, İsmail
dc.contributor.authorToptaş, Orçun
dc.contributor.authorÖzan, Fatih
dc.contributor.authorŞener, İsmail
dc.date.accessioned2021-06-23T19:37:07Z
dc.date.available2021-06-23T19:37:07Z
dc.date.issued2014
dc.departmentBAİBÜ, Diş Hekimliği Fakültesi, Ağız Diş ve Çene Cerrahisi Ana Bilim Dalıen_US
dc.description.abstractBackground: Alveolar osteitis (AO) is a commonly seen post-operative complication during the wound-healing period after permanent tooth extraction or surgical removal of impacted third molar teeth. Objectives: The aim of this clinical study was to evaluate the effects of administration of the topical hemostatic agent Ankaferd Blood Stopper (ABS) into the socket on AO formation after impacted mandibular third molar extraction. Patients and Methods: Bilaterally, 100 half-impacted mandibular third molars were extracted in 50 patients. Then, 1.0 mL ABS was administered to achieve hemostasis in one half of the sockets and as a control, the other half was irrigated with 1.0 mL physiological serum after surgery. Results: There was no statistically significant difference in terms of AO formation (P > 0.05) between the extraction sites. However, the postoperative pain in ABS administration sites was higher than in the other sites for the first 2 days after surgery (P < 0.05). Conclusions: The results showed that ABS administration did not increase the incidence of AO formation. Thus, ABS can be used safely for hemostasis after impacted mandibular third molar surgery.en_US
dc.identifier.doi10.4103/1119-3077.122847
dc.identifier.endpage80en_US
dc.identifier.issn1119-3077
dc.identifier.issue1en_US
dc.identifier.pmid24326812en_US
dc.identifier.scopus2-s2.0-84892550408en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage75en_US
dc.identifier.urihttps://doi.org/10.4103/1119-3077.122847
dc.identifier.urihttps://hdl.handle.net/20.500.12491/8108
dc.identifier.volume17en_US
dc.identifier.wosWOS:000329520100016en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorTek, Mustafa
dc.institutionauthorAkkaş, İsmail
dc.institutionauthorToptaş, Orçun
dc.institutionauthorÖzan, Fatih
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofNigerian Journal Of Clinical Practiceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAlveolar Osteitisen_US
dc.subjectAnkaferd Blood Stopperen_US
dc.subjectHemostasisen_US
dc.subjectThird Molaren_US
dc.titleEffects of the topical hemostatic agent Ankaferd Blood Stopper on the incidence of alveolar osteitis after surgical removal of an impacted mandibular third molaren_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
mustafa-tek-8108.pdf
Boyut:
503.59 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin/Full text